International validation of our technology, team, and market potential.
Highlighted milestones that demonstrate the international relevance and market potential of our molecular platform and biomedical applications.
Ranked among the Global Top 10 in the SelectUSA CleanTech program, highlighting strong scalability and international market potential.
Selected as a Web Summit Impact Startup, recognizing the global relevance and innovation potential of the MACS platform.
Awarded for outstanding execution, team capability, and commercialization readiness.
Voted by audience and industry participants, reflecting strong product resonance and market interest.
Recognized for innovation potential and future growth as an emerging startup.
Featured in a Los Angeles Times special supplement, this story adds international visibility to our broader recognition across awards, startup platforms, and innovation ecosystems.
This feature complements our existing recognition across awards, startup platforms, and innovation ecosystems, expanding our visibility to a broader international audience.
Read the feature →These recognitions help communicate why MACS matters to partners, investors, and institutions evaluating high-impact biomedical innovation.
Recognition across global innovation platforms reinforces the technical relevance and differentiation of MACS
Awards in startup and demo environments indicate clear market interest and translational opportunity
International visibility supports future collaboration, market entry, and ecosystem expansion
We welcome collaboration opportunities in hemostatic materials, oncology innovation, translational research, and global market development